Source link : https://www.newshealth.biz/health-news/approval-in-endometrial-cancer-expanded-masks-at-cancer-centers-npr-reporter-dies/
The FDA expanded the approval of dostarlimab (Jemperli) plus chemotherapy for primary advanced or recurrent endometrial cancer to include patients with mismatch repair proficient/microsatellite stable tumors. A survey study in Menopause showed that 37% of women were unaware that postmenopausal bleeding is a key symptom of endometrial cancer. Meanwhile, only 38% of surveyed Americans said […]
Author : News Health
Publish date : 2024-08-02 19:19:47
Copyright for syndicated content belongs to the linked Source.
Categories